About Par Pharmaceutical Companies (NYSE:PRX)
Par Pharmaceutical Companies, Inc. is a holding company that, principally through its wholly owned operating subsidiary, Par Pharmaceutical, Inc., is in the business of developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States. The Company operates primarily in the United States as two business segments: Par Pharmaceutical (Par), its generic products division, and Strativa Pharmaceuticals (Strativa), its branded products division. In February 17, 2012, the Company acquired Edict Pharmaceuticals Private Limited. On November 17, 2011, it acquired Anchen Incorporated and its subsidiary, Anchen Pharmaceuticals, Inc. In October 2011, it acquired rights to three products from Teva Pharmaceuticals in connection with Teva's acquisition of Cephalon. In September 2012, certain affiliates of TPG acquired the Company.
Industry, Sector and Symbol
Industry Generic Pharmaceuticals
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Par Pharmaceutical Companies (NYSE:PRX) Frequently Asked Questions
What is Par Pharmaceutical Companies' stock symbol?
Par Pharmaceutical Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRX."
Who are some of Par Pharmaceutical Companies' key competitors?
Who are Par Pharmaceutical Companies' key executives?
Par Pharmaceutical Companies' management team includes the folowing people:
- Paul V. Campanelli, Chief Executive Officer (Age 54)
- Michael A. Tropiano, Chief Financial Officer, Executive Vice President (Age 57)
- Terrance John Coughlin, Chief Operating Officer (Age 52)
- Thomas J. Haughey, Chief Administrative Officer, General Counsel (Age 51)
How do I buy Par Pharmaceutical Companies stock?
Shares of Par Pharmaceutical Companies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Par Pharmaceutical Companies?
Par Pharmaceutical Companies' mailing address is 1 Ram Ridge Rd, CHESTNUT RIDGE, NY 10977-6714, United States. The healthcare company can be reached via phone at +1-845-5735500.
MarketBeat Community Rating for Par Pharmaceutical Companies (PRX)MarketBeat's community ratings are surveys of what our community members think about Par Pharmaceutical Companies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Par Pharmaceutical Companies (NYSE:PRX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Par Pharmaceutical Companies (NYSE:PRX) Earnings History and Estimates Chart
Par Pharmaceutical Companies (NYSE PRX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Par Pharmaceutical Companies (NYSE:PRX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Par Pharmaceutical Companies (NYSE:PRX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Par Pharmaceutical Companies (NYSE PRX)
No insider trades for this company have been tracked by MarketBeat.com
Par Pharmaceutical Companies (NYSE PRX) News Headlines
Par Pharmaceutical Companies (NYSE:PRX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Par Pharmaceutical Companies (NYSE:PRX) Income Statement, Balance Sheet and Cash Flow Statement
Par Pharmaceutical Companies (NYSE PRX) Stock Chart for Tuesday, February, 20, 2018